{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:27:12Z","timestamp":1780410432316,"version":"3.54.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmpb.2026.109434","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:12:13Z","timestamp":1778339533000},"page":"109434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antiangiogenic therapy enhances CAR-T cell efficacy in solid tumors: Insights from a hybrid multiscale model"],"prefix":"10.1016","volume":"283","author":[{"given":"Sayyed Mohammad Ali","family":"Mortazavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Firoozabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2026.109434_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.108607","article-title":"Targeting CD84 protein on myeloid-derived suppressor cells as a novel immunotherapy in solid tumors","volume":"261","author":"Mobini","year":"2025","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2024.108135","article-title":"Immunotherapy efficacy prediction through a feature re-calibrated 2.5D neural network","volume":"249","author":"Xu","year":"2024","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"L","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmpb.2026.109434_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0005","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","article-title":"Clinical lessons learned from the first leg of the CAR T cell journey","volume":"25","author":"Majzner","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmpb.2026.109434_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1141","article-title":"Engineering chimeric antigen receptor T cells for solid tumour therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cmpb.2026.109434_bib0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-024-03315-3","article-title":"Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cmpb.2026.109434_bib0008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","article-title":"Deciphering and reversing tumor immune suppression","volume":"39","author":"Motz","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cmpb.2026.109434_bib0009","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.7150\/thno.76854","article-title":"Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cmpb.2026.109434_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.106829","article-title":"A new AI-assisted scoring system for PD-L1 expression in NSCLC","volume":"221","author":"Huang","year":"2022","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0011","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment","volume":"20","author":"Hou","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cmpb.2026.109434_bib0012","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s10237-024-01891-x","article-title":"Towards a framework for predicting immunotherapy outcome: a hybrid multiscale mathematical model of immune response to vascular tumor growth","volume":"23","author":"Mortazavi","year":"2024","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: defining mechanisms of T cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0015","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1002\/bit.27863","article-title":"Chemo-mechanistic multi-scale model of a three-dimensional tumor microenvironment to quantify the chemotherapy response of cancer","volume":"118","author":"Nikmaneshi","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.cmpb.2026.109434_bib0016","series-title":"Proceedings of the National Academy of Sciences","first-page":"3728","article-title":"Combining microenvironment normalization strategies to improve cancer immunotherapy","volume":"117","author":"Mpekris","year":"2020"},{"key":"10.1016\/j.cmpb.2026.109434_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043226","article-title":"The combination of immune checkpoint blockade with tumor vessel normalization as a promising therapeutic strategy for breast cancer: an overview of preclinical and clinical studies","volume":"24","author":"Melaiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmpb.2026.109434_bib0018","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.ymthe.2018.05.003","article-title":"Dominant-negative TGF-\u03b2 receptor enhances PSMA-targeted Human CAR T cell proliferation and augments prostate cancer eradication","volume":"26","author":"Kloss","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cmpb.2026.109434_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J. Immunother Cancer"},{"key":"10.1016\/j.cmpb.2026.109434_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymthe.2019.10.010","article-title":"The vascular disrupting agent CA4P improves the antitumor efficacy of CAR-T cells in preclinical models of solid Human tumors","volume":"28","author":"Deng","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cmpb.2026.109434_bib0021","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-10-0153","article-title":"Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer","volume":"70","author":"Shrimali","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cmpb.2026.109434_bib0022","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1378843","article-title":"Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model","volume":"7","author":"Bocca","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cmpb.2026.109434_bib0023","article-title":"Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors","volume":"1877","author":"Akbari","year":"2022","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.cmpb.2026.109434_bib0024","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/0008-5472.CAN-06-4102","article-title":"Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model","volume":"67","author":"Jain","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cmpb.2026.109434_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mvr.2019.01.005","article-title":"Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor \u2014 computational approach","volume":"123","author":"Kashkooli","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.cmpb.2026.109434_bib0026","series-title":"Proceedings of the National Academy of Sciences","first-page":"2662","article-title":"Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies","volume":"116","author":"Voutouri","year":"2019"},{"key":"10.1016\/j.cmpb.2026.109434_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13345-4","article-title":"A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis","volume":"12","author":"Kashkooli","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109434_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104507","article-title":"Simulation of 3D centimeter-scale continuum tumor growth at sub-millimeter resolution via distributed computing","volume":"134","author":"Goodin","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.cmpb.2026.109434_bib0029","article-title":"A mathematical model coupling tumor growth and angiogenesis","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.cmpb.2026.109434_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ces.2023.118965","article-title":"Application of combination chemotherapy in two dimensional tumor growth model with heterogeneous vasculature","volume":"280","author":"Lampropoulos","year":"2023","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.cmpb.2026.109434_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.108700","article-title":"A study on brain tumor dynamics in two-dimensional irregular domain with variable-order time-fractional derivative","volume":"264","author":"Sakariya","year":"2025","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/srep36992","article-title":"Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis","volume":"6","author":"Norton","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109434_bib0033","first-page":"1","article-title":"A review of cell-based computational modeling in cancer biology","author":"Metzcar","year":"2019","journal-title":"JCO Clin Cancer Inf."},{"key":"10.1016\/j.cmpb.2026.109434_bib0034","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0320","article-title":"A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition","volume":"14","author":"Gong","year":"2017","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.cmpb.2026.109434_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007468","article-title":"A mechanistic integrative computational model of macrophage polarization: implications in human pathophysiology","volume":"15","author":"Zhao","year":"2019","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106481","article-title":"Cellular-automaton model for tumor growth dynamics: virtualization of different scenarios","volume":"153","author":"Valentim","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.cmpb.2026.109434_bib0037","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/10\/6\/065003","article-title":"Dynamics of tissue topology during cancer invasion and metastasis","volume":"10","author":"Munn","year":"2013","journal-title":"Phys. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2024.108331","article-title":"An agent-based method to estimate 3D cell migration trajectories from 2D measurements: quantifying and comparing T vs CAR-T 3D cell migration","volume":"255","author":"Camacho-Gomez","year":"2024","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.108917","article-title":"Mimicking cancer therapy in an agent-based model: the case of hepatoblastoma","volume":"269","author":"Ravoni","year":"2025","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-59658-0","article-title":"A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth","volume":"10","author":"Nikmaneshi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109434_bib0041","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pr7010037","article-title":"Multiscale agent-based and hybrid modeling of the Tumor immune microenvironment","volume":"7","author":"Norton","year":"2019","journal-title":"Process. (Basel)"},{"key":"10.1016\/j.cmpb.2026.109434_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007190","article-title":"3D Multi-cell simulation of tumor growth and angiogenesis","volume":"4","author":"Shirinifard","year":"2009","journal-title":"PLoS. One"},{"key":"10.1016\/j.cmpb.2026.109434_bib0043","article-title":"Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.cmpb.2026.109434_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011131","article-title":"Computational simulations of tumor growth and treatment response: benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization","volume":"19","author":"Nikmaneshi","year":"2023","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0045","article-title":"Multiscale modeling of tumor growth and angiogenesis: evaluation of tumor-targeted therapy","volume":"17","author":"Nivlouei","year":"2021","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006460","article-title":"In-silico dynamic analysis of cytotoxic drug administration to solid tumours: effect of binding affinity and vessel permeability","volume":"14","author":"Vavourakis","year":"2018","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005259","article-title":"A validated multiscale In-silico model for mechano-sensitive tumour angiogenesis and growth","volume":"13","author":"Vavourakis","year":"2017","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0048","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s44341-024-00002-2","article-title":"Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy","volume":"1","author":"Hadjigeorgiou","year":"2024","journal-title":"Npj Biol. Phys. Mech."},{"key":"10.1016\/j.cmpb.2026.109434_bib0049","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jtbi.2017.02.018","article-title":"How tumour-induced vascular changes alter angiogenesis: insights from a computational model","volume":"419","author":"St\u00e9phanou","year":"2017","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0050","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1038\/s41598-018-27303-6","article-title":"Mathematical modeling of the function of Warburg effect in tumor microenvironment","volume":"8","author":"Shamsi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109434_bib0051","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/wsbm.102","article-title":"Hybrid models of tumor growth","volume":"3","author":"Rejniak","year":"2011","journal-title":"WIREs Syst. Biol. Med."},{"key":"10.1016\/j.cmpb.2026.109434_bib0052","series-title":"Modeling Tumor Vasculature: Molecular, Cellular, and Tissue Level Aspects and Implications","first-page":"105","article-title":"A hybrid discrete-continuum model of tumour induced angiogenesis","author":"Anderson","year":"2012"},{"key":"10.1016\/j.cmpb.2026.109434_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2024.108046","article-title":"A simple agent-based hybrid model to simulate the biophysics of glioblastoma multiforme cells and the concomitant evolution of the oxygen field","volume":"246","author":"Saucedo-Mora","year":"2024","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0054","doi-asserted-by":"crossref","first-page":"379","DOI":"10.34768\/amcs-2023-0027","article-title":"On the analysis of a mathematical model of CAR\u2013T cell therapy for glioblastoma: insights from a mathematical model","volume":"33","author":"Bodnar","year":"2023","journal-title":"Int. J. Appl. Math. Comput. Sci."},{"issue":"20","key":"10.1016\/j.cmpb.2026.109434_bib0055","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3390\/cancers13205171","article-title":"A mathematical modeling approach for targeted radionuclide and chimeric antigen receptor T cell combination therapy","volume":"13","author":"Adhikarla","year":"2021","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.cmpb.2026.109434_bib0056","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11538-021-00869-5","article-title":"Modeling CAR T-cell therapy with patient preconditioning","volume":"83","author":"Owens","year":"2021","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0057","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11538-025-01417-1","article-title":"Mathematical model of CAR T-cell therapy for a B-cell lymphoma lymph node","volume":"87","author":"Sabir","year":"2025","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0058","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63125-5","article-title":"In silico study of heterogeneous tumour-derived organoid response to CAR T-cell therapy","volume":"14","author":"Luque","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109434_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.849363","article-title":"Mapping CAR T-cell design space using agent-based models","volume":"9","author":"Prybutok","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cmpb.2026.109434_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12272-022-01389-z","article-title":"Crosstalk between angiogenesis and immune regulation in the tumor microenvironment","volume":"45","author":"Kim","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.cmpb.2026.109434_bib0061","article-title":"Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors","volume":"1879","author":"Wachholz","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.cmpb.2026.109434_bib0062","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-4682-6-5","article-title":"FEM-based oxygen consumption and cell viability models for avascular pancreatic islets","volume":"6","author":"Buchwald","year":"2009","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.cmpb.2026.109434_bib0063","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ceb.2012.02.002","article-title":"VEGF signaling inside vascular endothelial cells and beyond","volume":"24","author":"Eichmann","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0064","series-title":"Proceedings of the National Academy of Sciences","article-title":"Computational modeling of three-dimensional ECM-rigidity sensing to guide directed cell migration","volume":"115","author":"Kim","year":"2018"},{"key":"10.1016\/j.cmpb.2026.109434_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11538-025-01433-1","article-title":"The impact of T-cell exhaustion dynamics on tumour\u2013Immune interactions and tumour growth","volume":"87","author":"Lai","year":"2025","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cmpb.2026.109434_bib0067","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nri.2015.16","article-title":"T cell migration, search strategies and mechanisms","volume":"16","author":"Krummel","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0068","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11538-022-01095-3","article-title":"A hybrid discrete\u2013Continuum modelling approach to explore the impact of T-cell infiltration on anti-tumour immune response","volume":"84","author":"Almeida","year":"2022","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0069","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11538-023-01201-z","article-title":"Modeling the role of immune cell conversion in the tumor-immune microenvironment","volume":"85","author":"Moffett","year":"2023","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116052","article-title":"Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model","volume":"170","author":"Takeuchi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cmpb.2026.109434_bib0071","first-page":"16","article-title":"Strategies for improving CAR T cell persistence in solid tumors","author":"Wittling","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.cmpb.2026.109434_bib0072","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mcm.2004.07.021","article-title":"Mathematical modelling of the influence of blood rheological properties upon adaptative tumour-induced angiogenesis","volume":"44","author":"St\u00e9phanou","year":"2006","journal-title":"Math. Comput. Model."},{"key":"10.1016\/j.cmpb.2026.109434_bib0073","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10237-022-01587-0","article-title":"Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment","volume":"21","author":"Nikmaneshi","year":"2022","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0074","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1208\/s12249-021-01933-y","article-title":"PD-1 siRNA-encapsulated solid lipid nanoparticles downregulate PD-1 expression by macrophages and inhibit tumor growth","volume":"22","author":"Hanafy","year":"2021","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.cmpb.2026.109434_bib0075","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.2147\/IJN.S388234","article-title":"Combined Ibuprofen-nanoconjugate micelles with E-selectin for effective Sunitinib anticancer therapy","volume":"17","author":"Zeng","year":"2022","journal-title":"Int J Nanomed."},{"key":"10.1016\/j.cmpb.2026.109434_bib0076","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1038\/sj.onc.1210348","article-title":"Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF\/SF autocrine pathway","volume":"26","author":"Hu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cmpb.2026.109434_bib0077","article-title":"Expression analysis and implication of Rab1A in gastrointestinal relevant tumor","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2026.109434_bib0078","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00262-022-03318-x","article-title":"Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model","volume":"72","author":"Qiao","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cmpb.2026.109434_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1358478","article-title":"Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy","volume":"15","author":"Adhikarla","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0080","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s11538-019-00591-3","article-title":"Modeling pancreatic cancer dynamics with immunotherapy","volume":"81","author":"Hu","year":"2019","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0081","series-title":"Proceedings of the National Academy of Sciences","first-page":"3749","article-title":"Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma","volume":"108","author":"Keunen","year":"2011"},{"key":"10.1016\/j.cmpb.2026.109434_bib0082","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cmpb.2026.109434_bib0083","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/0008-5472.CAN-13-1989","article-title":"Benefits of vascular normalization are dose and time dependent\u2014letter","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cmpb.2026.109434_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012908","article-title":"Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome","volume":"21","author":"Santurio","year":"2025","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.cmpb.2026.109434_bib0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy\u2013Temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260726001884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260726001884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:54:39Z","timestamp":1780408479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260726001884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":85,"alternative-id":["S0169260726001884"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2026.109434","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiangiogenic therapy enhances CAR-T cell efficacy in solid tumors: Insights from a hybrid multiscale model","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2026.109434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109434"}}